Medication info
Losatek Tablet (Losartan Potassium)

Losatek Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201906380 · Approved 2019.09.10 · Insurance code 057600170

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. Hypertension - If blood pressure is not controlled with this medicine alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No initial dose adjustment is needed in elderly patients 75 years of age or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is needed. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective circulating blood volume: For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric and adolescent patients 6 years of age or older, weighing 20 kg or more but less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients 6 years of age or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication helps lower and control blood pressure in patients with hypertension. It is particularly effective in preventing and treating kidney complications in patients suffering from hypertension along with type 2 diabetes. This allows for improvement in both blood pressure management and kidney health, thus it is used for treating hypertension and related kidney diseases.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. Hypertension - If blood pressure is not controlled with this medicine alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No initial dose adjustment is needed in elderly patients 75 years of age or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is needed. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective circulating blood volume: For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric and adolescent patients 6 years of age or older, weighing 20 kg or more but less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients 6 years of age or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with an allergy to this medication, severe liver impairment, certain hereditary diseases, or women of childbearing potential should not take this medication. Elderly patients, those with impaired kidney function, or patients with hyperkalemia should use this medication cautiously, ensuring that blood pressure does not drop too low. During treatment, symptoms such as dizziness may occur, so caution should be exercised when driving or operating hazardous machinery. Although this medication lowers blood pressure, it may occasionally cause side effects such as headache, muscle pain, indigestion, and cough. It’s important to regularly monitor liver function, kidney function, and electrolyte status through blood tests. Particularly, potassium levels may increase, so it is advisable not to take potassium supplements or medications containing potassium simultaneously. When combined with other antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs, potential interactions may occur, so consult with a physician or pharmacist. In case of overdose, hypotension, rapid heartbeat, or loss of consciousness may occur, so it is crucial to visit a medical institution immediately. It is recommended not to use this medication in children or patients with severely impaired kidney function, as safety has not been established. Store this medication out of reach of children and be cautious not to change the storage container arbitrarily.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 126 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm exfoliation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning and pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vasodilation
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • creatine kinase elevation
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • erythematous skin disease
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.